Scholars Central

ArticlePublished 22 Jul 2024

Efficacy of Roxadustat for Secondary Hyperparathyroidism

Authors: Qiong Wu, X. P. Liao, Qin Zou, Chen Ting Li, Y. Cui

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This study summarizes the efficacy of roxadustat for secondary hyperparathyroidism. 65 individuals with secondary hyperparathyroidism were selected between May 2022 and May 2023 and were divided into control (n=30) and observation groups (n=35). The control group was treated with iron polysaccharide complex capsules+erythropoietin while the observation group was given roxadustat. Comparative analysis was conducted in terms of efficacy, drug safety which included fatigue, nausea and vomiting, myodynia and hypercalcemia. Further, serum biochemical indices like red blood cell count, hematocrit value and hemoglobin concentration were observed and compared. Then, microinflammation indicators like C-reactive protein, beta 2-microglobulin and interleukin-6 were also evaluated. Finally, the quality of life according to the World Health Organization quality of life was evaluated. The results revealed markedly higher efficacy, and a comparable incidence of adverse drug events in the observation group compared with the control group. In addition, the observation group had evidently elevated red blood cell count, hematocrit value, hemoglobin and World Health Organization quality of life scores compared with the baseline and the control group, as well as significantly higher reduced C-reactive protein, beta 2-microglobulin and interleukin-6. It can be concluded that, roxadustat is effective and safe for secondary hyperparathyroidism patients which can ameliorate anemia-related indicators and the microinflammation indicators can enhance the quality of life.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Indian Journal of Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Qiong Wu”
  • BylineArticles whose byline prints “X. P. Liao”
  • BylineArticles whose byline prints “Qin Zou”
  • BylineArticles whose byline prints “Chen Ting Li”
  • BylineArticles whose byline prints “Y. Cui”